“Accelerating U.S. ‐ Israel Neuroscience & Neurotechnology Collaborations”

 “Accelerating U.S. ‐ Israel Neuroscience & Neurotechnology Collaborations”

Wednesday, September 12, 2012 – 8:30 am – 5:00 pm

The National Academy of Sciences Building – 2100 C St. NW Washington, D.C. 20037

The human brain is the most complex object of study in the history of science. Brain research affects the lives of all human beings. The complexity of the brain creates significant challenges that requires a multidisciplinary effort by physicians, researchers, engineers, chemists, mathematicians and others, teaming up to search for new methods and more accurate diagnostics to enhance our understanding of basic brain functions. Recent advances in brain research, including developments in memory and brain training, will revolutionize outcomes for patients and bring significant benefits to society as a whole.

The U.S.-Israel Neurotechnology and Neuroscience Conference will bring together leading scientists from academia and industry to highlight recent developments in the study of brain function and brain disorders. Cutting edge technologies that will lead to breakthroughs in the diagnosis and treatment of neurological disorders will be showcased, and opportunities for cooperation between companies and researchers in both countries will be explored.
A Partial List of Confirmed Speakers:

Dr. Henry Brem
The Johns Hopkins Hospital
Dr. Jeff Nye
VP & Global Head, Neuroscience External Innovation,
Janssen Pharmaceutical Companies of J&J
Prof. John Disterhoft
Northwestern University
Prof. Andrew Schwartz
University of Pittsburgh
Mr. Bill Doyle

Chairman, Novo-Cure & Managing Director, WFD VenturesProf. Alcino Silva
UCLAProf. Yadin Dudai
Weizmann Institute of ScienceMr. Michael Singer
President and CEO, BrainScopeProf. Bernice Grafstein
Weil Cornell Medical SchoolProf. Zahava Solomon
Tel-Aviv UniversityThe Honorable Patrick Kennedy
Founder, “One Mind for Brain Research”Prof. Hermona Soreq
Hebrew UniversityCOL Geoffrey Ling, M.D., Ph.D.
Defense Sciences Office, DARPAProf. Eilon Vaadia
Hebrew UniversityMr. Zack Lynch
Executive Director, Neurotechnology Industry OrganizationDr. Imad Yunis
CEO, Alpha OmegaDr. Jacobo Mintzer
Medical University of South CarolinaDr. Vincent Zurawski
Chairman and CEO, Avraham PharmaceuticalsMr. Thomas Foo
Chief Scientist, MRI, GE Global ResearchDr. Giora Yaron
Founder & Co-Chairman, Itamar MedicalGeneral Pete Chiarelli
CEO, One Mind For Research

For more information, please contact:

BIRD Foundation – Ms. Limor Nakar-Vincent, at limorn@birdf.com;
BSF – Dr. Heni Hering at heni@bsf.org.il;
USISTF – Ms. Ann Liebschutz at email